Zura Bio Limited

NASDAQ
ZURA
Stock
Yield per half year: -66%
Dividend yield: 0%
Sector: Healthcare

Share chart Zura Bio Limited

Extended chart Simple chart
Financial Markets by TradingView

About Zura Bio Limited

Zura Bio Limited, биотехнологическая компания клинической стадии, занимается разработкой новых лекарств от иммунных и воспалительных заболеваний. Он разрабатывает ZB-168, анти-IL7R ингибитор, который воздействует на заболевания, вызываемые биологическими путями IL7 и TSLP; и торудокимаб, моноклональное антитело, нейтрализующее IL33, которое находится на стадии 2 клинических испытаний. Компания базируется в Сан-Диего, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2021-09-03
ISIN KYG9TY5A1016
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт link
Цена ао 1.02
Change price per day: 0% (1.02)
Change price per week: -4.67% (1.07)
Change price per month: -25.55% (1.37)
Change price per 3 month: -20.31% (1.28)
Change price per half year: -66% (3)
Change price per year: -80.57% (5.25)
Change price per year to date: -56.03% (2.32)
All parameters

Grade

Underestimation
Title Value Grade
P/S 0 0
P/BV 1.2 9
P/E 0 0
EV/EBITDA -0.285 0
Total: 3.38
Efficiency
Title Value Grade
ROA, % -32.38 0
ROE, % -44.03 0
Total: 0
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0
Debt
Title Value Grade
Debt/EBITDA 0 10
Total: 8.8
Growth impulse
Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 4698.03 10
Yield EPS, % -252.13 0
Total: 4
More

Main owners

Institutions Volume Share, %
Great Point Partners LLC 3 295 000 7.56
Suvretta Capital Management, LLC 2 850 000 6.54
Deep Track Capital, LP 2 523 000 5.79
Armistice Capital, LLC 1 824 000 4.18
Blackrock Inc. 1 108 944 2.54
Citadel Advisors Llc 692 794 1.59
Vanguard Group Inc 555 045 1.27
Geode Capital Management, LLC 486 688 1.12
SILVERARC CAPITAL MANAGEMENT, LLC 462 997 1.06
State Street Corporation 191 010 0.44

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Mr. David Brady Head of Business Development 125.05k
Dr. Someit Sidhu M.D. Founder & Director 442.94k 1989 (36 years)
Mr. Verender S. Badial Chief Financial Officer 374.92k 1972 (53 years)
Dr. Michael D. Howell Ph.D. Chief Scientific Officer & Head of Translational Medicine 1.97M 1977 (48 years)
Ms. Kimberly Ann Davis Chief Legal Officer & Corporate Secretary 2.16M 1968 (57 years)
Ms. Theresa Lowry Chief Human Resources Officer N/A 1974 (51 year)
Mr. Robert Lisicki CEO & Director N/A 1967 (58 years)
Dr. Gary Whale Ph.D. Chief Technology Officer N/A 1974 (51 year)
Dr. Kiran Nistala MBBS, Ph.D. Chief Medical Officer & Head of Development N/A 1973 (52 years)

About company

Address: United States, San Diego. CA, 4225 Executive Square - Open in google maps, Open in yandex maps
Website: https://zurabio.com